Literature DB >> 26920353

Evolution of cancer risk assessment and counseling related to psychological, financial and legal implications.

Carrie Snyder1.   

Abstract

Cancer risk assessment, genetic counseling and genetic testing have experienced advances and changes over the past two decades due to improved technology, legal movements to protect those at an increased risk for cancer due to genetics, as well as advances in detection, prevention and treatment. This brief article will provide a summary of these advances over three eras of cancer genetics: pre-discovery of the more common high impact genes, namely BRCA1/BRCA2 and the mismatch repair genes associated with Lynch syndrome; the time during which the genes were being discovered; and current day.

Entities:  

Keywords:  Cancer genetics; Genetic counseling; Genetic testing; Hereditary breast–ovarian cancer; Hereditary cancer; Lynch syndrome

Mesh:

Substances:

Year:  2016        PMID: 26920353     DOI: 10.1007/s10689-016-9890-8

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  15 in total

1.  Supreme Court rules against gene patents.

Authors:  Bridget M Kuehn
Journal:  JAMA       Date:  2013-07-24       Impact factor: 56.272

2.  What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.

Authors:  C Lerman; C Hughes; S J Lemon; D Main; C Snyder; C Durham; S Narod; H T Lynch
Journal:  J Clin Oncol       Date:  1998-05       Impact factor: 44.544

3.  Comparison of extended colectomy and limited resection in patients with Lynch syndrome.

Authors:  Nagendra Natarajan; Patrice Watson; Edibaldo Silva-Lopez; Henry T Lynch
Journal:  Dis Colon Rectum       Date:  2010-01       Impact factor: 4.585

4.  Keeping pace with the times--the Genetic Information Nondiscrimination Act of 2008.

Authors:  Kathy L Hudson; M K Holohan; Francis S Collins
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

Review 5.  Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.

Authors:  Murray Joseph Casey; Agnes B Colanta
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

6.  Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.

Authors:  Michael J Callahan; Christopher P Crum; Fabiola Medeiros; David W Kindelberger; Julia A Elvin; Judy E Garber; Colleen M Feltmate; Ross S Berkowitz; Michael G Muto
Journal:  J Clin Oncol       Date:  2007-09-01       Impact factor: 44.544

Review 7.  CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients.

Authors:  Patrick A Ott; F Stephen Hodi; Caroline Robert
Journal:  Clin Cancer Res       Date:  2013-10-01       Impact factor: 12.531

Review 8.  Immunotherapy for colorectal cancer.

Authors:  Shigeo Koido; Toshifumi Ohkusa; Sadamu Homma; Yoshihisa Namiki; Kazuki Takakura; Keisuke Saito; Zensho Ito; Hiroko Kobayashi; Mikio Kajihara; Kan Uchiyama; Seiji Arihiro; Hiroshi Arakawa; Masato Okamoto; Jianlin Gong; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

9.  Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Authors:  John Burn; Anne-Marie Gerdes; Finlay Macrae; Jukka-Pekka Mecklin; Gabriela Moeslein; Sylviane Olschwang; Diane Eccles; D Gareth Evans; Eamonn R Maher; Lucio Bertario; Marie-Luise Bisgaard; Malcolm G Dunlop; Judy W C Ho; Shirley V Hodgson; Annika Lindblom; Jan Lubinski; Patrick J Morrison; Victoria Murday; Raj Ramesar; Lucy Side; Rodney J Scott; Huw J W Thomas; Hans F Vasen; Gail Barker; Gillian Crawford; Faye Elliott; Mohammad Movahedi; Kirsi Pylvanainen; Juul T Wijnen; Riccardo Fodde; Henry T Lynch; John C Mathers; D Timothy Bishop
Journal:  Lancet       Date:  2011-10-27       Impact factor: 79.321

Review 10.  PARP inhibitors in the management of breast cancer: current data and future prospects.

Authors:  Luca Livraghi; Judy E Garber
Journal:  BMC Med       Date:  2015-08-13       Impact factor: 8.775

View more
  4 in total

Review 1.  Incorporating Colorectal Cancer Genetic Risk Assessment into Gastroenterology Practice.

Authors:  Benjamin Stern; Thomas McGarrity; Maria Baker
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

2.  How does genetic testing influence anxiety, depression, and quality of life? A hereditary breast and ovarian cancer syndrome suspects trial.

Authors:  Francisca Fernanda Barbosa Oliveira; Paulo Goberlânio de Barros Silva; Rosane Oliveira de Sant'Ana; Clarissa Gondim Picanço de Albuquerque; Maria Júlia Barbosa Bezerra; Deysi Viviana Tenazoa Wong; Flávio da Silveira Bitencourt; Isabelle Joyce de Lima Silva-Fernandes; Marcos Venicio Alves Lima
Journal:  Support Care Cancer       Date:  2020-11-05       Impact factor: 3.603

Review 3.  Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications.

Authors:  Andreia Brandão; Paula Paulo; Manuel R Teixeira
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

4.  Defining health-related quality of life in localized and advanced stages of breast cancer - the first step towards hereditary cancer genetic counseling.

Authors:  Tamara Žigman; Ivana Lukša; Gloria Mihaljević; Maša Žarković; Iva Kirac; Danko Velimir Vrdoljak; Ljiljana Šerman
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.